Safety of a new malaria vaccine in healthy adults
Treatments studied
Part of Infections clinical trials.
This study tests a new malaria vaccine in healthy adults. You will receive the vaccine and then be exposed to the malaria parasite in a controlled setting to check if the vaccine protects you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy adult between 18 and 45 years old.
- You have never received a malaria vaccine before.
- You do not have any serious medical conditions like sickle cell disease, seizures, or heart problems.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
- You agree not to travel to a malaria-prone area for the duration of the trial.
- You are willing to use effective birth control if you could become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new combination of experimental malaria vaccines to see if they are safe and help protect against malaria. It includes both adults and young children in malaria-affected areas.
This study tests a genetically modified malaria parasite that is intentionally given to healthy volunteers through a mosquito bite. The goal is to see if it is safe and to learn how the immune system responds, which could help develop a malaria vaccine.
This study tests a new investigational drug (GSK4425689A) for the first time in humans. It is a healthy volunteer study to check the safety, side effects, and how the drug moves through the body. It may help in the future development of treatments for malaria.
This study tests a new long-acting injection to prevent malaria. It checks safety and how the body handles the drug in healthy adults and adolescents in Rwanda.
This Phase 1/2 study tests a new vaccine meant to protect young children against malaria. If you qualify, your baby would get the study vaccine and be followed for about 12 months to check safety and early signs of protection.
This trial tests a new malaria drug (MMV055), alone or with another drug (MMV371), to see if it is safe and how the body processes it. It is for healthy people who want to help find new malaria treatments.
Hear when a new Malaria Falciparum trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.